Order Entry
Canada
ContactUsLinkComponent
Human pan IFN-alpha ELISA Kit
Human pan IFN-alpha ELISA Kit
  MSPP-02001
 :  
undefined
Human pan IFN-alpha ELISA Kit
  MSPP-02001
 :  02001
 :  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products, please provide identification that includes your business name and shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of identification are:

  • • Issued document with your organization's Federal Tax ID Number
  • • Government issued document with your organization's Resale Tax ID Number
  • • Any other Government ID that includes the business name and address

Avantor will not lift restrictions for residential shipping addresses.

 

  • Host:
  • Primary antibody reactivity:
    Human
  • Target protein:
    Interferon-alpha
  • Size:
    10 units
  • Environmentally Preferable:
  • Cat. no.:
    MSPP-02001

 

 

For detection and measurement of human pan interferon-alpha.

The Human pan Interferon-alpha (IFN-α) ELISA Kit is designed for the quantitative detection and measurement of human IFN-α in biological fluids such as serum, plasma, and cell culture supernatants. IFN-α is primarily produced by macrophages resulting from viral infections and activates anti-viral and immunomodulatory activities in target cells. IFN-α is secreted as multiple subtypes; this kit is specific for subtypes 1/13, 2, 4, 5, 6, 7, 8, 10, 14, 16, and 17.

The assay is based on the sandwich ELISA method, in which samples are added to ELISA strip plates pre-coated with capture antibodies specific for the cytokine. The captured cytokine is detected by addition of a biotinylated detection antibody, followed by streptavidin-horseradish peroxidase, which binds the biotinylated antibody. Addition of the chromogenic enzyme substrate 3,3’,5,5’ tetramethylbenzidine (TMB) results in a colored product with an intensity directly proportional to the concentration of cytokine in the sample. The concentration of the cytokine is determined by comparison to a serial dilution of the cytokine standard analyzed in parallel.

 : Product restrictions: (i) Customer shall not make products or any portion of them in any way, shape or form, including as a component of another product available for the purpose of further resale or alter or remove the Product label and the Supplier’s mark of origin without express written permission of Supplier and (ii) Customer is familiar with Supplier’s restrictions on the use of the products and shall use the products in compliance with such restrictions and the applicable Supplier Product Information sheet (collectively, the 'Product Restrictions').